The International Premium Cigar and Pipe Retailers Association (“IPCPR”) and Cigar Rights of America (“CRA”) filed a joint comment in response to the U.S. Food and Drug Administration’s ongoing review of how it should define and treat premium cigars. This process, known as an Advanced Notice of Proposed Rulemaking – marked a major milestone for premium cigar retailers, manufacturers, consumers and the industry at large. It was an opportunity for IPCPR, CRA and other stakeholders […]
Browsing Tag